BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pedrazza L, Cunha AA, Luft C, Nunes NK, Schimitz F, Gassen RB, Breda RV, Donadio MV, de Souza Wyse AT, Pitrez PMC, Rosa JL, de Oliveira JR. Mesenchymal stem cells improves survival in LPS-induced acute lung injury acting through inhibition of NETs formation. J Cell Physiol. 2017;232:3552-3564. [PMID: 28112391 DOI: 10.1002/jcp.25816] [Cited by in Crossref: 38] [Cited by in F6Publishing: 43] [Article Influence: 7.6] [Reference Citation Analysis]
Number Citing Articles
1 Zhu R, Yan T, Feng Y, Liu Y, Cao H, Peng G, Yang Y, Xu Z, Liu J, Hou W, Wang X, Li Z, Deng L, Wang S, Li J, Han Q, Li H, Shan G, Cao Y, An X, Yan J, Zhang Z, Li H, Qu X, Zhu J, Zhou S, Wang J, Zhang F, Gao J, Jin R, Xu D, Ma YQ, Huang T, Peng S, Zheng Z, Stambler I, Gilson E, Lim LW, Moskalev A, Cano A, Chakrabarti S, Ulfhake B, Su H, Xu H, Xu S, Wei F, Brown-Borg HM, Min KJ, Ellison-Hughes G, Caruso C, Jin K, Zhao RC. Mesenchymal stem cell treatment improves outcome of COVID-19 patients via multiple immunomodulatory mechanisms. Cell Res 2021. [PMID: 34702946 DOI: 10.1038/s41422-021-00573-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Haute GV, Luft C, Antunes GL, Silveira JS, de Souza Basso B, da Costa MS, Levorse VGS, Kaiber DB, Donadio MVF, Gracia-Sancho J, de Oliveira JR. Anti-inflammatory effect of octyl gallate in alveolar macrophages cells and mice with acute lung injury. J Cell Physiol 2020;235:6073-84. [PMID: 31970778 DOI: 10.1002/jcp.29536] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
3 Faner R, Rojas M. Building Strong Neighborhoods in the Lung with a Little Help from My Mesenchymal Stem Cells. Am J Respir Crit Care Med 2019;199:1176-8. [PMID: 30557513 DOI: 10.1164/rccm.201811-2153ED] [Reference Citation Analysis]
4 Noone PM, Reddy SP. Recent advances in dead cell clearance during acute lung injury and repair. Fac Rev 2021;10:33. [PMID: 33977286 DOI: 10.12703/r/10-33] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Kaspi H, Semo J, Abramov N, Dekel C, Lindborg S, Kern R, Lebovits C, Aricha R. MSC-NTF (NurOwn®) exosomes: a novel therapeutic modality in the mouse LPS-induced ARDS model. Stem Cell Res Ther 2021;12:72. [PMID: 33468250 DOI: 10.1186/s13287-021-02143-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
6 Ehnert S, Relja B, Schmidt-bleek K, Fischer V, Ignatius A, Linnemann C, Rinderknecht H, Huber-lang M, Kalbitz M, Histing T, Nussler AK. Effects of immune cells on mesenchymal stem cells during fracture healing. WJSC 2021;13:1670-98. [DOI: 10.4252/wjsc.v13.i11.1670] [Reference Citation Analysis]
7 Emukah C, Dittmar E, Naqvi R, Martinez J, Corral A, Moreira A, Moreira A. Mesenchymal stromal cell conditioned media for lung disease: a systematic review and meta-analysis of preclinical studies. Respir Res 2019;20:239. [PMID: 31666086 DOI: 10.1186/s12931-019-1212-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
8 Sadeghian Chaleshtori S, Mokhber Dezfouli MR, Jabbari Fakhr M. Mesenchymal stem/stromal cells: the therapeutic effects in animal models of acute pulmonary diseases. Respir Res 2020;21:110. [PMID: 32393278 DOI: 10.1186/s12931-020-01373-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
9 Ren H, Zhang Q, Wang J, Pan R. Comparative Effects of Umbilical Cord- and Menstrual Blood-Derived MSCs in Repairing Acute Lung Injury. Stem Cells Int 2018;2018:7873625. [PMID: 30050579 DOI: 10.1155/2018/7873625] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
10 Lian J, Lin J, Zakaria N, Yahaya BH. Acute Lung Injury: Disease Modelling and the Therapeutic Potential of Stem Cells. Adv Exp Med Biol 2020;1298:149-66. [PMID: 32424492 DOI: 10.1007/5584_2020_538] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
11 Jiang X, Yu M, Zhu T, Lou L, Chen X, Li Q, Wei D, Sun R. Kcnq1ot1/miR-381-3p/ETS2 Axis Regulates Inflammation in Mouse Models of Acute Respiratory Distress Syndrome. Mol Ther Nucleic Acids 2020;19:179-89. [PMID: 31841990 DOI: 10.1016/j.omtn.2019.10.036] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
12 Cruz T, Rojas M. Preclinical Evidence for the Role of Stem/Stromal Cells in Targeting ARDS. In: Burgess JK, Heijink IH, editors. Stem Cell-Based Therapy for Lung Disease. Cham: Springer International Publishing; 2019. pp. 199-217. [DOI: 10.1007/978-3-030-29403-8_11] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
13 Shetty R, Murugeswari P, Chakrabarty K, Jayadev C, Matalia H, Ghosh A, Das D. Stem cell therapy in coronavirus disease 2019: current evidence and future potential. Cytotherapy 2021;23:471-82. [PMID: 33257213 DOI: 10.1016/j.jcyt.2020.11.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Lanzoni G, Linetsky E, Correa D, Alvarez RA, Marttos A, Hirani K, Cayetano SM, Castro JG, Paidas MJ, Efantis Potter J, Xu X, Glassberg M, Tan J, Patel AN, Goldstein B, Kenyon NS, Baidal D, Alejandro R, Vianna R, Ruiz P, Caplan AI, Ricordi C. Umbilical Cord-derived Mesenchymal Stem Cells for COVID-19 Patients with Acute Respiratory Distress Syndrome (ARDS). CellR4 Repair Replace Regen Reprogram 2020;8:e2839. [PMID: 34164564 DOI: 10.32113/cellr4_20204_2839] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Fernández-Francos S, Eiro N, Costa LA, Escudero-Cernuda S, Fernández-Sánchez ML, Vizoso FJ. Mesenchymal Stem Cells as a Cornerstone in a Galaxy of Intercellular Signals: Basis for a New Era of Medicine. Int J Mol Sci 2021;22:3576. [PMID: 33808241 DOI: 10.3390/ijms22073576] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
16 Rogers CJ, Harman RJ, Bunnell BA, Schreiber MA, Xiang C, Wang FS, Santidrian AF, Minev BR. Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients. J Transl Med. 2020;18:203. [PMID: 32423449 DOI: 10.1186/s12967-020-02380-2] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 19.0] [Reference Citation Analysis]
17 Dulong J, Loisel S, Rossille D, Léonard S, Bescher N, Bezier I, Latour M, Monvoisin C, Monnier D, Bertheuil N, Roulois D, Tarte K. CD40L-expressing CD4+ T cells prime adipose-derived stromal cells to produce inflammatory chemokines. Cytotherapy 2022. [DOI: 10.1016/j.jcyt.2022.01.006] [Reference Citation Analysis]
18 Gorman E, Millar J, McAuley D, O'Kane C. Mesenchymal stromal cells for acute respiratory distress syndrome (ARDS), sepsis, and COVID-19 infection: optimizing the therapeutic potential. Expert Rev Respir Med 2021;15:301-24. [PMID: 33172313 DOI: 10.1080/17476348.2021.1848555] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
19 Franck T, Ceusters J, Graide H, Mouithys-Mickalad A, Serteyn D. Muscle Derived Mesenchymal Stem Cells Inhibit the Activity of the Free and the Neutrophil Extracellular Trap (NET)-Bond Myeloperoxidase. Cells 2021;10:3486. [PMID: 34943996 DOI: 10.3390/cells10123486] [Reference Citation Analysis]
20 Mokhber Dezfouli MR, Jabbari Fakhr M, Sadeghian Chaleshtori S, Dehghan MM, Vajhi A, Mokhtari R. Intrapulmonary autologous transplant of bone marrow-derived mesenchymal stromal cells improves lipopolysaccharide-induced acute respiratory distress syndrome in rabbit. Crit Care. 2018;22:353. [PMID: 30572913 DOI: 10.1186/s13054-018-2272-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
21 Gu Z, Li L, Li Q, Tan H, Zou Z, Chen X, Zhang Z, Zhou Y, Wei D, Liu C, Huang Q, Maegele M, Cai D, Huang M. Polydatin alleviates severe traumatic brain injury induced acute lung injury by inhibiting S100B mediated NETs formation. Int Immunopharmacol 2021;98:107699. [PMID: 34147911 DOI: 10.1016/j.intimp.2021.107699] [Reference Citation Analysis]
22 Eiro N, Cabrera JR, Fraile M, Costa L, Vizoso FJ. The Coronavirus Pandemic (SARS-CoV-2): New Problems Demand New Solutions, the Alternative of Mesenchymal (Stem) Stromal Cells. Front Cell Dev Biol 2020;8:645. [PMID: 32766251 DOI: 10.3389/fcell.2020.00645] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
23 Wang MY, Zhou TY, Zhang ZD, Liu HY, Zheng ZY, Xie HQ. Current therapeutic strategies for respiratory diseases using mesenchymal stem cells. MedComm (2020) 2021;2:351-80. [PMID: 34766151 DOI: 10.1002/mco2.74] [Reference Citation Analysis]
24 Zhang K, Gao Y, Deng Y, Zhou X, Zhu C, He Z, Lv D. Studies on the effects of bone marrow stem cells on mitochondrial function and the alleviation of ARDS. Mol Cell Biochem 2021;476:93-107. [PMID: 32845436 DOI: 10.1007/s11010-020-03888-3] [Reference Citation Analysis]
25 Machhi J, Shahjin F, Das S, Patel M, Abdelmoaty MM, Cohen JD, Singh PA, Baldi A, Bajwa N, Kumar R, Vora LK, Patel TA, Oleynikov MD, Soni D, Yeapuri P, Mukadam I, Chakraborty R, Saksena CG, Herskovitz J, Hasan M, Oupicky D, Das S, Donnelly RF, Hettie KS, Chang L, Gendelman HE, Kevadiya BD. A Role for Extracellular Vesicles in SARS-CoV-2 Therapeutics and Prevention. J Neuroimmune Pharmacol 2021;16:270-88. [PMID: 33544324 DOI: 10.1007/s11481-020-09981-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
26 Raza SS, Khan MA. Mesenchymal Stem Cells: A new front emerge in COVID19 treatment. Cytotherapy 2020. [DOI: 10.1016/j.jcyt.2020.07.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 6.5] [Reference Citation Analysis]
27 Qin H, Zhao A. Mesenchymal stem cell therapy for acute respiratory distress syndrome: from basic to clinics. Protein Cell. 2020. [PMID: 32519302 DOI: 10.1007/s13238-020-00738-2] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 13.0] [Reference Citation Analysis]
28 Xiao K, Xie LX. Advances in mesenchymal stem cell-mediated tissue repair of lung injury. Chronic Dis Transl Med 2021;7:75-8. [PMID: 34136766 DOI: 10.1016/j.cdtm.2021.02.002] [Reference Citation Analysis]
29 Fengyun W, LiXin Z, Xinhua Q, Bin F. Mesenchymal Stromal Cells Attenuate Infection-Induced Acute Respiratory Distress Syndrome in Animal Experiments: A Meta-Analysis. Cell Transplant 2020;29:963689720969186. [PMID: 33164559 DOI: 10.1177/0963689720969186] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
30 Kovtun A, Messerer DAC, Scharffetter-Kochanek K, Huber-Lang M, Ignatius A. Neutrophils in Tissue Trauma of the Skin, Bone, and Lung: Two Sides of the Same Coin. J Immunol Res 2018;2018:8173983. [PMID: 29850639 DOI: 10.1155/2018/8173983] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 9.5] [Reference Citation Analysis]
31 Behnke J, Kremer S, Shahzad T, Chao CM, Böttcher-Friebertshäuser E, Morty RE, Bellusci S, Ehrhardt H. MSC Based Therapies-New Perspectives for the Injured Lung. J Clin Med 2020;9:E682. [PMID: 32138309 DOI: 10.3390/jcm9030682] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 25.5] [Reference Citation Analysis]
32 Chen X, Wu S, Tang L, Ma L, Wang F, Feng H, Meng J, Han Z. Mesenchymal stem cells overexpressing heme oxygenase-1 ameliorate lipopolysaccharide-induced acute lung injury in rats. J Cell Physiol 2019;234:7301-19. [PMID: 30362554 DOI: 10.1002/jcp.27488] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 9.3] [Reference Citation Analysis]
33 Lin F, Ichim TE, Pingle S, Jones LD, Kesari S, Ashili S. Mesenchymal stem cells as living anti-inflammatory therapy for COVID-19 related acute respiratory distress syndrome. World J Stem Cells 2020; 12(10): 1067-1079 [PMID: 33178392 DOI: 10.4252/wjsc.v12.i10.1067] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
34 Lu T, Zhang J, Cai J, Xiao J, Sui X, Yuan X, Li R, Li Y, Yao J, Lv G, Chen X, Chen H, Zeng K, Liu Y, Chen W, Chen G, Yang Y, Zheng J, Zhang Y. Extracellular vesicles derived from mesenchymal stromal cells as nanotherapeutics for liver ischaemia–reperfusion injury by transferring mitochondria to modulate the formation of neutrophil extracellular traps'. Biomaterials 2022. [DOI: 10.1016/j.biomaterials.2022.121486] [Reference Citation Analysis]
35 Byrnes D, Masterson CH, Artigas A, Laffey JG. Mesenchymal Stem/Stromal Cells Therapy for Sepsis and Acute Respiratory Distress Syndrome. Semin Respir Crit Care Med 2021;42:20-39. [PMID: 32767301 DOI: 10.1055/s-0040-1713422] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
36 Dong WW, Feng Z, Zhang YQ, Ruan ZS, Jiang L. Potential mechanism and key genes involved in mechanical ventilation and lipopolysaccharide‑induced acute lung injury. Mol Med Rep 2020;22:4265-77. [PMID: 33000237 DOI: 10.3892/mmr.2020.11507] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
37 Shin NR, Park SH, Ko JW, Ryu HW, Jeong SH, Kim JC, Shin DH, Lee HS, Shin IS. Artemisia argyi attenuates airway inflammation in lipopolysaccharide induced acute lung injury model. Lab Anim Res 2017;33:209-15. [PMID: 29046695 DOI: 10.5625/lar.2017.33.3.209] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
38 Antunes GL, Silveira JS, Kaiber DB, Luft C, da Costa MS, Marques EP, Ferreira FS, Breda RV, Wyse ATS, Stein RT, Pitrez PM, da Cunha AA. Cholinergic anti-inflammatory pathway confers airway protection against oxidative damage and attenuates inflammation in an allergic asthma model. J Cell Physiol 2020;235:1838-49. [PMID: 31332773 DOI: 10.1002/jcp.29101] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
39 Hu X, Liu L, Wang Y, Yu Y, Li Z, Liu Y, Chai J, Cantore S. Human Umbilical Cord-Derived Mesenchymal Stem Cells Alleviate Acute Lung Injury Caused by Severe Burn via Secreting TSG-6 and Inhibiting Inflammatory Response. Stem Cells International 2022;2022:1-12. [DOI: 10.1155/2022/8661689] [Reference Citation Analysis]
40 Caretti A, Peli V, Colombo M, Zulueta A. Lights and Shadows in the Use of Mesenchymal Stem Cells in Lung Inflammation, a Poorly Investigated Topic in Cystic Fibrosis. Cells 2019;9:E20. [PMID: 31861724 DOI: 10.3390/cells9010020] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
41 Abbasi A, Kukia NR, Froushani SMA, Hashemi SM. Nicotine and caffeine alter the effects of the LPS- primed mesenchymal stem cells on the co-cultured neutrophils. Life Sciences 2018;199:41-7. [DOI: 10.1016/j.lfs.2018.03.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
42 Millar JE, Bartnikowski N, Passmore MR, Obonyo NG, Malfertheiner MV, von Bahr V, Redd MA, See Hoe L, Ki KK, Pedersen S, Boyle AJ, Baillie JK, Shekar K, Palpant N, Suen JY, Matthay MA, McAuley DF, Fraser JF. Combined Mesenchymal Stromal Cell Therapy and Extracorporeal Membrane Oxygenation in Acute Respiratory Distress Syndrome. A Randomized Controlled Trial in Sheep. Am J Respir Crit Care Med 2020;202:383-92. [PMID: 32293914 DOI: 10.1164/rccm.201911-2143OC] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 7.5] [Reference Citation Analysis]
43 Kosutova P, Kolomaznik M, Calkovska A, Mokra D, Mikolka P. Nitric-Oxide-Releasing Dexamethasone Derivative NCX-1005 Improves Lung Function and Attenuates Inflammation in Experimental Lavage-Induced ARDS. Pharmaceutics 2021;13:2092. [PMID: 34959373 DOI: 10.3390/pharmaceutics13122092] [Reference Citation Analysis]
44 Horie S, Gonzalez HE, Laffey JG, Masterson CH. Cell therapy in acute respiratory distress syndrome. J Thorac Dis. 2018;10:5607-5620. [PMID: 30416812 DOI: 10.21037/jtd.2018.08.28] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 8.0] [Reference Citation Analysis]
45 Lopes-Pacheco M, Robba C, Rocco PRM, Pelosi P. Current understanding of the therapeutic benefits of mesenchymal stem cells in acute respiratory distress syndrome. Cell Biol Toxicol 2020;36:83-102. [PMID: 31485828 DOI: 10.1007/s10565-019-09493-5] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 9.0] [Reference Citation Analysis]
46 Markov A, Thangavelu L, Aravindhan S, Zekiy AO, Jarahian M, Chartrand MS, Pathak Y, Marofi F, Shamlou S, Hassanzadeh A. Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders. Stem Cell Res Ther 2021;12:192. [PMID: 33736695 DOI: 10.1186/s13287-021-02265-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
47 Chen G, Yue A, Wang M, Ruan Z, Zhu L. The Exosomal lncRNA KLF3-AS1 From Ischemic Cardiomyocytes Mediates IGF-1 Secretion by MSCs to Rescue Myocardial Ischemia-Reperfusion Injury. Front Cardiovasc Med 2021;8:671610. [PMID: 34621793 DOI: 10.3389/fcvm.2021.671610] [Reference Citation Analysis]
48 Ehnert S, Relja B, Schmidt-Bleek K, Fischer V, Ignatius A, Linnemann C, Rinderknecht H, Huber-Lang M, Kalbitz M, Histing T, Nussler AK. Effects of immune cells on mesenchymal stem cells during fracture healing. World J Stem Cells 2021; 13(11): 1667-1695 [PMID: 34909117 DOI: 10.4252/wjsc.v13.i11.1667] [Reference Citation Analysis]
49 Wang W, Lei W, Jiang L, Gao S, Hu S, Zhao ZG, Niu CY, Zhao ZA. Therapeutic mechanisms of mesenchymal stem cells in acute respiratory distress syndrome reveal potentials for Covid-19 treatment. J Transl Med 2021;19:198. [PMID: 33971907 DOI: 10.1186/s12967-021-02862-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
50 Kan X, Chen Y, Huang B, Fu S, Guo W, Ran X, Cao Y, Xu D, Cheng J, Yang Z, Xu Y. Effect of Palrnatine on lipopolysaccharide-induced acute lung injury by inhibiting activation of the Akt/NF-κB pathway. J Zhejiang Univ Sci B 2021;22:929-40. [PMID: 34783223 DOI: 10.1631/jzus.B2000583] [Reference Citation Analysis]
51 Zhao F, Ma Q, Yue Q, Chen H. SARS-CoV-2 Infection and Lung Regeneration. Clin Microbiol Rev 2022;:e0018821. [PMID: 35107300 DOI: 10.1128/cmr.00188-21] [Reference Citation Analysis]
52 Li R, Li Y, Dong X. Preconditioning mesenchymal stromal cells with flagellin enhances the anti‑inflammatory ability of their secretome against lipopolysaccharide‑induced acute lung injury. Mol Med Rep 2020;22:2753-66. [PMID: 32945411 DOI: 10.3892/mmr.2020.11380] [Reference Citation Analysis]
53 Kao TI, Chen PJ, Wang YH, Tseng HH, Chang SH, Wu TS, Yang SH, Lee YT, Hwang TL. Bletinib ameliorates neutrophilic inflammation and lung injury by inhibiting Src family kinase phosphorylation and activity. Br J Pharmacol 2021. [PMID: 34131920 DOI: 10.1111/bph.15597] [Reference Citation Analysis]